MicroRNA epigenetic alterations in human cancer: One step forward in diagnosis and treatment
Open Access
- 24 December 2007
- journal article
- review article
- Published by Wiley in International Journal of Cancer
- Vol. 122 (5) , 963-968
Abstract
MicroRNAs (miRNAs) are approximately 22 nt non‐coding RNAs, which regulate gene expression in a sequence‐specific manner via translational inhibition or messenger RNA (mRNA) degradation. Since the discovery of their fundamental mechanisms of action, the field of miRNAs has opened a new era in the understanding of small noncoding RNAs. By molecular cloning and bioinformatic approaches, miRNAs have been identified in viruses, plants and animals. miRNAs are predicted to negatively target up to one‐third of human mRNAs. Cancer is a complex genetic disease caused by abnormalities in gene structure and expression. Previous studies have heavily focused on protein‐coding genes; however, accumulating evidence is revealing an important role of miRNAs in cancer. Epigenetics is defined as mitotically and/or meiotically heritable changes in gene expression that are not accompanied by changes in DNA sequence. Given the critical roles of miRNAs and epigenetics in cancer, characterizing the epigenetic regulation of miRNAs will provide novel opportunities for the development of cancer biomarkers and/or the identification of new therapeutic targets in the foreseeable future.Keywords
This publication has 88 references indexed in Scilit:
- BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomasThe Journal of Pathology, 2005
- c-Myc-regulated microRNAs modulate E2F1 expressionNature, 2005
- A microRNA polycistron as a potential human oncogeneNature, 2005
- Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammalsNature, 2005
- The Microprocessor complex mediates the genesis of microRNAsNature, 2004
- Processing of primary microRNAs by the Microprocessor complexNature, 2004
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004
- Initial sequencing and analysis of the human genomeNature, 2001
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000
- CpG Islands in vertebrate genomesJournal of Molecular Biology, 1987